Reimagined Kura’s complete visual identity, investor presentations, and digital design system ahead of a successful $25M Series B round.
A pioneering synthetic biology startup needed a world-class brand identity that communicated both rigorous scientific credibility and visionary innovation.
Their existing identity was fragmented, generic, and failed to reflect the high-impact value of their proprietary drug discovery platform.
Successfully closed $25M Series B funding and won corporate identity praise across industry media.
Common questions regarding deliverables, tech stack, and partnership models.
Tell us about your next initiative and discover how our digital & AI solutions can accelerate your growth.